首站-论文投稿智能助手
典型文献
TRIM25 activates AKT/mTOR by inhibiting PTEN via K63-linked polyubiquitination in non-small cell lung cancer
文献摘要:
The PTEN/AKT/mTOR signaling pathway is frequently dysregulated in non-small cell lung cancer(NSCLC),but the mechanisms are not well-understood.The present study found that the ubiquitin ligase TRIM25 is highly expressed in NSCLC tissues and promotes NSCLC cell survival and tumor growth.Mechanistic studies revealed that TRIM25 binds to PTEN and mediates its K63-linked ubiquitination at K266.This modification prevents the plasma membrane translocation of PTEN and reduces its phosphatase activity therefore accumulating PI(3,4,5)P3.TRIM25 thus activates the AKT/mTOR signaling.Moreover,we found that the antibacterial nitroxoline can activate PTEN by reducing its K63-linked polyubiquitination and sensitizes NSCLC to cisplatin-induced apoptosis.This study thus identified a novel modulation on the PTEN signaling pathway by TRIM25 and provides a potential target for NSCLC treatment.
文献关键词:
作者姓名:
Yuan-ming He;Xiu-min Zhou;Shuo-yi Jiang;Zu-bin Zhang;Bi-yin Cao;Jin-bao Liu;Yuan-ying Zeng;Jun Zhao;Xin-liang Mao
作者机构:
Guangdong Key Laboratory of Protein Modification and Degradation,School of Basic Medical Sciences,Guangzhou Medical University,Guangzhou 511436,China;Department of Pharmacology,College of Pharmaceutical Sciences,Soochow University,Suzhou 215123,China;Department of Oncology,The First Affiliated Hospital of Soochow University,Suzhou 215106,China;Department of Oncology,Suzhou Municipal Hospital,Suzhou 215100,China;Department of Thoracic Surgery,The First Affiliated Hospital of Soochow University,Suzhou 215106,China
引用格式:
[1]Yuan-ming He;Xiu-min Zhou;Shuo-yi Jiang;Zu-bin Zhang;Bi-yin Cao;Jin-bao Liu;Yuan-ying Zeng;Jun Zhao;Xin-liang Mao-.TRIM25 activates AKT/mTOR by inhibiting PTEN via K63-linked polyubiquitination in non-small cell lung cancer)[J].中国药理学报(英文版),2022(03):681-691
A类:
polyubiquitination,K266,nitroxoline
B类:
TRIM25,activates,AKT,mTOR,by,inhibiting,PTEN,via,K63,linked,small,cell,lung,cancer,signaling,pathway,frequently,dysregulated,NSCLC,but,mechanisms,are,not,well,understood,present,study,found,that,ligase,highly,expressed,tissues,promotes,survival,tumor,growth,Mechanistic,studies,revealed,binds,mediates,its,This,modification,prevents,plasma,membrane,translocation,reduces,phosphatase,activity,therefore,accumulating,P3,thus,Moreover,antibacterial,reducing,sensitizes,cisplatin,induced,apoptosis,identified,novel,modulation,provides,potential,target,treatment
AB值:
0.508192
相似文献
N6?methyladenosine modification of CENPK mRNA by ZC3H13 promotes cervical cancer stemness and chemoresistance
Xian Lin;Feng Wang;Jian Chen;Jing Liu;Yi?Bin Lin;Li Li;Chuan?Ben Chen;Qin Xu-Departments of Gynecology,Fujian Cancer Hospital and Fujian Medical University Cancer Hospital,Fujian Medical University,Fuzhou 350014,China;Department of Radiation Oncology,Fujian Cancer Hospital and Fujian Medical University Cancer Hospital,Fujian Medical University,Fuzhou 350014,China;Shenzhen Key Laboratory of Immunity and Inflammatory Diseases,Peking University Shenzhen Hospital,Shenzhen Peking University?the Hong Kong University of Science and Technology Medical Center,Shenzhen 518036,Guangdong,China;Outpatient Department,Fujian Hospital of People's Armed Police,Fujian Medical University,Fuzhou 350014,China
IL13Rα1 prevents a castration resistant phenotype of prostate cancer by targeting hexokinase 2 for ubiquitin-mediated degradation
Tingting Feng;Jing Wang;Kai Cheng;Qiqi Lu;Ru Zhao;Shiguan Wang;Qingyun Zhang;Luna Ge;Jihong Pan;Guanhua Song;Lin Wang-Department of Pathology,School of Basic Medical Sciences,Shandong University,Jinan 250012,China;Department of Pathology,The Fourth People's Hospital of Jinan,Jinan 250031,China;Department of PET-CT,Shandong Cancer Hospital and Institute,Shandong First Medical University and Shandong Academy of Medical Sciences,Jinan 250002,China;The Second Hospital,Cheeloo College of Medicine,Shandong University Medical School,Jinan 250012,China;Biomedical Sciences College&Shandong Medicinal Biotechnology Centre,Key Lab for Biotech-Drugs of National Health Commission,Key Lab for Rare&Uncommon Diseases of Shandong Province,Shandong First Medical University&Shandong Academy of Medical Sciences,Jinan 250002,China;Department of Biochemistry and Molecular Biology,Shandong University School of Basic Medical Sciences,Jinan 250012,China;Institute of Basic Medicine,Shandong Academy of Medical Sciences,Shandong First Medical University&Shandong Academy of Medical Sciences,Jinan 250002,China;Department of Oncology,The First Affiliated Hospital of Shandong First Medical University,Jinan 250014,China
Glycolytic potential enhanced by blockade of pyruvate influx into mitochondria sensitizes prostate cancer to detection and radiotherapy
Huan Xu;Junyi Chen;Zhi Cao;Xi Chen;Caihong Huang;Jin Ji;Yalong Xu;Junfeng Jiang;Yue Wang;Guowang Xu;Lina Zhou;Jingyi He;Xuedong Wei;Jason Boyang Wu;Zhong Wang;Shancheng Ren;Fubo Wang-Department of Urology,Shanghai Changhai Hospital,Second Military Medical University,Shanghai 200433,China;Department of Urology,Shanghai Ninth People's Hospital,Shanghai 200011,China;Department of Urology,the Second Affiliated Hospital of Fujian Medical University,Quanzhou 362000,China;Department of Urology,No.971 Hospital of the People's Liberation Army Navy,Qingdao 266000,China;Center for Genomic and Personalized Medicine,Guangxi Key Laboratory for Genomic and Personalized Medicine,Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine,Guangxi Medical University,Nanning 530021,China;Research Center of Developmental Biology,Second Military Medical University,Shanghai 200433,China;Dalian Institute of Chemical Physics,Chinese Academy of Sciences,Dalian 116023,China;Department of Urology,the First Affiliated Hospital of Soochow University,Suzhou 215006,China;Department of Pharmaceutical Sciences,College of Pharmacy and Pharmaceutical Sciences,Washington State University,Spokane,WA 99202,USA
EGFR signaling promotes nuclear translocation of plasma membrane protein TSPAN8 to enhance tumor progression via STAT3-mediated transcription
Xiaoqing Lu;Liwei An;Guangjian FanTi;Lijuan Zang;Weiyi Huang;Junjian Li;Jun Liu;Weiyu Ge;Yuwei Huang;Jingxuan Xu;Shaoqian Du;Yuan Cao;Tianhao Zhou;Huijing Yin;Li Yu;Shi Jiao;Hongxia Wang-State Key Laboratory of Oncogenes and Related Genes,Department of Oncology,Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,China;Department of Breast Surgery,Shanxi Cancer Hospital,Chinese Academy of Medical Sciences,Taiyuan,Shanxi,China;Department of Medical Ultrasound,Shanghai Tenth People's Hospital,Tongji University Cancer Center,School of Medicine,Tongji University,Shanghai,China;Precision Research Center for Refractory Diseases,Institute for Clinical Research,Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,China;Department of Pathology,Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,China;State Key Laboratory of Membrane Biology,Tsinghua-Peking University Joint Center for Life Sciences,School of Life Science,Tsinghua University,Beijing,China;State Key Laboratory of Genetic Engineering,School of Life Sciences,Fudan University,Shanghai,China
Histone deacetylase inhibitors inhibit cervical cancer growth through Parkin acetylation-mediated mitophagy
Xin Sun;Yuhan Shu;Guiqin Ye;Caixia Wu;Mengting Xu;Ruilan Gao;Dongsheng Huang;Jianbin Zhang-Department of Oncology,Cancer Center of Zhejiang Provincial People's Hospital,Affiliated People's Hospital,Hangzhou Medical College,Hangzhou 310014,China;College of Biomedical Engineering&Instrument Science,Zhejiang University,Hangzhou 310028,China;Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine of Zhejiang Province,Hangzhou Medical College,Hangzhou 310014,China;Clinical Research Institute,Zhejiang Provincial People,s Hospital,Affiliated People,s Hospital,Hangzhou Medical College,Hangzhou 310014,China;Department of Hematology,the First Affiliated Hospital of Zhejiang Chinese Medical University,Hangzhou 310006,China
FOX03 mutation predicting gefitinib-induced hepatotoxicity in NSCLC patients through regulation of autophagy
Shaoxing Guan;Xi Chen;Youhao Chen;Guohui Wan;Qibiao Su;Heng Liang;Yunpeng Yang;Wenfeng Fang;Yan Huang;Hongyun Zhao;Wei Zhuang;Shu Liu;Fei Wang;Wei Feng;Xiaoxu Zhang;Min Huang;Xueding Wang;Li Zhang-Laboratory of Drug Metabolism and Pharmacokinetics,School of Pharmaceutical Sciences,Sun Yat-sen University,Guangzhou 510060,China;State Key Laboratory of Oncology in South China,Collaborative Innovation Center for Cancer Medicine,Sun Yat-sen University Cancer Center,Guangzhou 510060,China;College of Health Science,Guangdong Pharmaceutical University,Guangzhou 510006,China;Sun Yat-sen Memorial Hospital,Sun Yat-sen University,Guangzhou 510080,China;Ersha Department of Pharmacy,the Second Affiliated Hospital of Guangzhou University of Chinese Medicine,Guangzhou 510105,China
Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
Fanxiang Yin;Ran Zhao;Dhilli Rao Gorja;Xiaorong Fu;Ning Lu;Hai Huang;Beibei Xu;Hanyong Chen;Jung-Hyun Shim;Kangdong Liu;Zhi Li;Kyle Vaughn Laster;Zigang Dong;Mee-Hyun Lee-Department of Pathophysiology,School of Basic Medical Sciences,Zhengzhou University,Zhengzhou 450001,China;China-US(Henan)Hormel Cancer Institute,Zhengzhou 450008,China;Translational Medical Center,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;The Hormel Institute,University of Minnesota,Austin,MN 55912,USA;Department of Biomedicine,Health&Life Convergencen Science,BK21 Four,College of Pharmacy,Mokpo National University,Jeonnam 58554,Republic of Korea;The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;Department of General Surgery,the Affiliated Tumor Hospital of Zhengzhou University,Zhengzhou 450008,China;College of Korean Medicine,Dongshin University,Naju 58245,Republic of Korea
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。